A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/737 (2006.01) A61P 17/06 (2006.01)
Patent
CA 2533329
The present invention relates to the use of an alkaline or alkaline earth metal chondroitin sulphate, which comes from an enzymatic hydrolysis of animal cartilage, for the preparation of a medicament for the treatment or prevention of psoriasis with skin affection in a mammal. Preferably the sodium chondroitin sulphate has an average molecular weight between 10,000 and 20,000 daltons, and is administered orally.
L'invention concerne l'utilisation du sulfate de chondroïtine de métal alcalin ou alcalino-terreux, issu de l'hydrolyse enzymatique de cartilage animal, pour l'élaboration de médicament utilisé dans le traitement ou la prévention du psoriasis avec affection de la peau chez un mammifère. De préférence, le sulfate de chondroïtine a une masse moléculaire moyenne comprise entre 10 000 et 20 000 daltons, et il est administré par voie orale.
Perez Lopez Montserrat
Verges Milano Josep
Vila Pahi Francisco Javier
Bioiberica S.a.
Johnston Wassenaar Llp
LandOfFree
New therapeutic use of chondroitin sulphate does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with New therapeutic use of chondroitin sulphate, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and New therapeutic use of chondroitin sulphate will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1428550